Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2435 (LINC02435)

Target
LINC02435
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2435 (LINC02435) is a member of the long intergenic non-coding RNAs (lincRNAs), a subclass of long non-coding RNAs that are transcribed from genomic regions not overlapping with protein-coding genes and are typically longer than 200 nucleotides[1][3][7]. LincRNAs, including LINC02435, are thought to regulate gene expression through a variety of mechanisms such as modulation of chromatin structure, stabilization or destabilization of target RNAs, recruitment or scaffolding of protein complexes, and participating in transcriptional regulation, often exhibiting tissue-specific functions[1][3]. While the general biological properties of lincRNAs are increasingly understood, specific functional and disease associations for LINC02435 are not well characterized in the current literature. LincRNAs’ dysregulation has been linked to diseases, particularly in cancer and developmental contexts, though there is no direct evidence to consider LINC02435 a therapeutic target or druggable receptor/enzyme at this time[1][3][5][7].

Other names
LINC02435long intergenic non-coding RNA 2435
02

Biological functions

Chromatin remodelingRegulation of gene expressionRNA stabilizationTranscription regulationScaffolding of proteinsModulation of genome architecture
03

Disease associations

Potential involvement in cancer and diverse gene regulatory processes (generic to lincRNAs; specific evidence for LINC02435 may be lacking)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2435 (LINC02435).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2435 (LINC02435).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call